SRX Global acquires stake in Vistagen Therapeutics

Reuters2026/08/04 09:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

SRX Global acquired a stake in Vistagen Therapeutics, taking a minority equity position in the Nasdaq-listed biotech.
The investment targets Vistagen’s late-stage neuroscience pipeline built around intranasal “pherine” product candidates.
SRX Global described Vistagen shares as undervalued, signaling plans for engagement with management and the board on value creation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Global Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040500PRIMZONEFULLFEED9802973) on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

SRX Global acquires stake in Vistagen Therapeutics

You may also like

Crypto prices